Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions

NCT07251153 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male and Female Volunteers

Interventions

DRUG: EYP651/Vonafexor low dose
DRUG: EYP651/Vonafexor high dose
DRUG: EYP651/CYP3A4 inhibitor
DRUG: EYP651/Transporter substrate
DRUG: EYP651/CYP2C8 and CYP2C9 substrate

Sponsor

Enyo Pharma